Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
This study is currently recruiting participants.
Verified September 2013 by INC Research
IPCA Laboratories Ltd.
Janssen R&D Ireland
Merck Sharp & Dohme Corp.
Roche Pharma AG
Strides Arcolab Ltd.
Teva Pharmaceuticals USA
ViiV Healthcare (represented by GlaxoSmithKline)
Information provided by (Responsible Party):
First received: November 27, 2006
Last updated: September 19, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||January 2015|
|Estimated Primary Completion Date:||No date given|